Company Filing History:
Years Active: 2016
Title: Yixian Long: Innovator in Central Nervous System Treatment
Introduction
Yixian Long, an esteemed inventor based in Glenview, Illinois, has made significant contributions to the field of medicine. With a focus on addressing central nervous system disorders, he has developed innovative methods that aim to improve the quality of life for patients grappling with various mental health conditions.
Latest Patents
Yixian Long holds a patent for a novel treatment method targeted at disorders and deficits of the central nervous system associated with diabetes, aging, and neurodegeneration. His patent outlines an effective approach for treating conditions such as attention deficit disorder, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, senile dementia, and schizophrenia. The treatment involves administering a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity, providing a promising avenue for therapeutic intervention.
Career Highlights
Currently, Yixian Long is employed at AbbVie Inc., where his research and innovations are contributing to advancements in the biopharmaceutical industry. His commitment to enhancing treatment options for patients facing severe health challenges demonstrates his dedication to the field and the impact of his work.
Collaborations
Throughout his career, Yixian has collaborated with esteemed colleagues, including R. Scott Bitner and Kaitlin E. Browman. Their combined expertise fosters an environment of innovation, enabling advancements in therapeutic solutions that address complex health issues.
Conclusion
Yixian Long stands out as a key inventor whose work is paving the way for new treatment modalities for central nervous system disorders. His patent and collaborations reflect a deep commitment to medical innovation, showcasing the importance of creativity and research in improving patient outcomes in a challenging healthcare landscape.